LC
EVO icon

Lindbrook Capital’s Evotec EVO Stock Holding History

Lindbrook Capital’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-536
Closed -$2.23K – 2829
2024
Q4 		$2.23K Sell
536
-176
-25% -$739 ﹤0.01% 2277
2024
Q3 		$2.6K Sell
712
-1,376
-66% -$5.46K ﹤0.01% 2265
2024
Q2 		$10K Buy
2,088
+1,784
+587% +$10K ﹤0.01% 1626
2024
Q1 		$2.38K Buy
304
+232
+322% +$1.82K ﹤0.01% 2179
2023
Q4 		$845 Hold
72
– – ﹤0.01% 2502
2023
Q3 		$711 Hold
72
– – ﹤0.01% 2447
2023
Q2 		$814 Hold
72
– – ﹤0.01% 2408
2023
Q1 		$752 Hold
72
– – ﹤0.01% 2516
2022
Q4 		$582 Buy
72
+20
+38% +$175 ﹤0.01% 2564
2022
Q3 		$0 Sell
52
-568
-92% -$6.78K ﹤0.01% 2702
2022
Q2 		$7K Buy
620
+508
+454% +$6.64K ﹤0.01% 1399
2022
Q1 		$2K Buy
+112
New +$1.92K ﹤0.01% 1980

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lindbrook Capital's EVO Position: Q1 2025 in Review

Lindbrook Capital sold out of Evotec (EVO) in Q1 2025, closing a stake of 536 shares — an estimated $2.23K sold.

Lindbrook Capital first reported a position in EVO in Q1 2022 and held it in 12 quarters. The position peaked at $10K in Q2 2024. 25 funds tracked by Wall St. Rank hold EVO as of Q1 2025.

  • Lindbrook Capital reported no remaining Evotec position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 536 Evotec shares in Q1 2025, an estimated $2.23K.
  • Lindbrook Capital first reported a position in Evotec in Q1 2022 and held it in 12 quarters.
  • Lindbrook Capital's Evotec position peaked at $10K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Evotec as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.